USD 49.54
(-3.54%)
Year | Net Debt | Net Debt Growth |
---|---|---|
2023 | -47.71 Million USD | 14.41% |
2022 | -55.75 Million USD | 6.32% |
2021 | -59.51 Million USD | -25.69% |
2020 | -47.35 Million USD | -16.85% |
2019 | -40.52 Million USD | -44.59% |
2018 | -28.02 Million USD | -53.95% |
2017 | -18.2 Million USD | -2.78% |
2016 | -17.71 Million USD | 8.54% |
2015 | -19.36 Million USD | -104.86% |
2014 | -9.45 Million USD | -285.06% |
2013 | -2.45 Million USD | -108.5% |
2012 | -1.17 Million USD | 0.0% |
Year | Net Debt | Net Debt Growth |
---|---|---|
2024 Q3 | -51.45 Million USD | -6.84% |
2024 Q1 | -43.18 Million USD | 9.49% |
2024 Q2 | -48.16 Million USD | -11.52% |
2023 Q3 | -44.59 Million USD | -2.35% |
2023 Q4 | -47.71 Million USD | -7.0% |
2023 Q2 | -43.57 Million USD | -7.78% |
2023 Q1 | -40.42 Million USD | 27.49% |
2023 FY | -47.71 Million USD | 14.41% |
2022 Q1 | -48.03 Million USD | 19.3% |
2022 Q4 | -55.75 Million USD | -4.58% |
2022 FY | -55.75 Million USD | 6.32% |
2022 Q3 | -53.31 Million USD | -7.04% |
2022 Q2 | -49.81 Million USD | -3.71% |
2021 Q3 | -55.82 Million USD | -6.24% |
2021 Q2 | -52.54 Million USD | -9.13% |
2021 FY | -59.51 Million USD | -25.69% |
2021 Q4 | -59.51 Million USD | -6.62% |
2021 Q1 | -48.14 Million USD | -1.68% |
2020 Q4 | -47.35 Million USD | -5.76% |
2020 FY | -47.35 Million USD | -16.85% |
2020 Q3 | -44.77 Million USD | -5.05% |
2020 Q2 | -42.62 Million USD | -2.11% |
2020 Q1 | -41.73 Million USD | -2.99% |
2019 Q2 | -29.35 Million USD | -10.52% |
2019 Q3 | -35.62 Million USD | -21.37% |
2019 Q4 | -40.52 Million USD | -13.76% |
2019 FY | -40.52 Million USD | -44.59% |
2019 Q1 | -26.55 Million USD | 5.25% |
2018 Q3 | -23.69 Million USD | -11.1% |
2018 Q2 | -21.33 Million USD | -6.16% |
2018 Q4 | -28.02 Million USD | -18.26% |
2018 FY | -28.02 Million USD | -53.95% |
2018 Q1 | -20.09 Million USD | -10.37% |
2017 Q1 | -17.45 Million USD | 1.45% |
2017 Q4 | -18.2 Million USD | 1.09% |
2017 FY | -18.2 Million USD | -2.78% |
2017 Q3 | -18.4 Million USD | -9.56% |
2017 Q2 | -16.8 Million USD | 3.76% |
2016 Q3 | -16 Million USD | -32.64% |
2016 Q4 | -17.71 Million USD | -10.68% |
2016 Q1 | -15.5 Million USD | 19.93% |
2016 FY | -17.71 Million USD | 8.54% |
2016 Q2 | -12.06 Million USD | 22.19% |
2015 FY | -19.36 Million USD | -104.86% |
2015 Q2 | -12.42 Million USD | -15.35% |
2015 Q1 | -10.77 Million USD | -13.96% |
2015 Q4 | -19.36 Million USD | -24.72% |
2015 Q3 | -15.52 Million USD | -24.96% |
2014 Q1 | -2.9 Million USD | -18.47% |
2014 Q3 | -18.11 Million USD | -325.11% |
2014 FY | -9.45 Million USD | -285.06% |
2014 Q4 | -9.45 Million USD | 47.81% |
2014 Q2 | -4.26 Million USD | -46.49% |
2013 FY | -2.45 Million USD | -108.5% |
2013 Q4 | -2.45 Million USD | 0.0% |
2013 Q1 | 1.94 Million USD | 0.0% |
2012 FY | -1.17 Million USD | 0.0% |
Name | Net Debt | Net Debt Difference |
---|---|---|
Accelerate Diagnostics, Inc. | 27.08 Million USD | 276.202% |
BrainsWay Ltd. | -10.32 Million USD | -362.395% |
Cerus Corporation | 84.35 Million USD | 156.571% |
Envoy Medical, Inc. | -3.81 Million USD | -1151.158% |
electroCore, Inc. | -9.95 Million USD | -379.349% |
Helius Medical Technologies, Inc. | -5.12 Million USD | -831.105% |
IceCure Medical Ltd | -9.93 Million USD | -380.362% |
Inogen, Inc. | -103.56 Million USD | 53.925% |
OrthoPediatrics Corp. | -9.26 Million USD | -414.936% |
Lucid Diagnostics Inc. | -3.64 Million USD | -1210.606% |
Monogram Orthopaedics, Inc. | -13.09 Million USD | -264.351% |
MaxCyte, Inc. | -27.76 Million USD | -71.88% |
NeuroOne Medical Technologies Corporation | -5.13 Million USD | -828.733% |
Nexalin Technology, Inc. | -575.76 Thousand USD | -8187.928% |
Orthofix Medical Inc. | 96.44 Million USD | 149.48% |
PAVmed Inc | 29.08 Million USD | 264.062% |
Rapid Micro Biosystems, Inc. | -16.93 Million USD | -181.712% |
RxSight, Inc. | -6.68 Million USD | -614.359% |
Sight Sciences, Inc. | -102.71 Million USD | 53.542% |
SI-BONE, Inc. | 5.72 Million USD | 934.105% |
TELA Bio, Inc. | -3.94 Million USD | -1108.386% |
Treace Medical Concepts, Inc. | 57.32 Million USD | 183.249% |
Vivos Therapeutics, Inc. | 352 Thousand USD | 13656.578% |
Acutus Medical, Inc. | 12.27 Million USD | 488.624% |
Talis Biomedical Corporation | -57.06 Million USD | 16.376% |
Spectral AI, Inc. | -3.5 Million USD | -1263.015% |
Nano-X Imaging Ltd. | -48.02 Million USD | 0.641% |
CVRx, Inc. | -59.95 Million USD | 20.41% |
DIH Holding US, Inc. Warrants | 1.98 Million USD | 2505.024% |
PetVivo Holdings, Inc. | 1.27 Million USD | 3834.954% |
Bioventus Inc. | 372.51 Million USD | 112.81% |
Venus Concept Inc. | 74.3 Million USD | 164.224% |
TriSalus Life Sciences, Inc. | -10.18 Million USD | -368.662% |
LivaNova PLC | 62.53 Million USD | 176.312% |
908 Devices Inc. | -115.09 Million USD | 58.54% |
Alphatec Holdings, Inc. | 320.7 Million USD | 114.879% |
Nemaura Medical Inc. | 9.92 Million USD | 580.797% |
NeuroPace, Inc. | 54.33 Million USD | 187.821% |
LENSAR, Inc. | -18.31 Million USD | -160.59% |
Apyx Medical Corporation | -5.15 Million USD | -826.406% |
Cutera, Inc. | 288.3 Million USD | 116.552% |
STRATA Skin Sciences, Inc. | 7.51 Million USD | 734.985% |
BioSig Technologies, Inc. | 262 Thousand USD | 18313.418% |
Anika Therapeutics, Inc. | -43.83 Million USD | -8.873% |
ClearPoint Neuro, Inc. | -9.19 Million USD | -418.743% |
Integra LifeSciences Holdings Corporation | 1.4 Billion USD | 103.396% |
Axonics, Inc. | -77.19 Million USD | 38.183% |
Outset Medical, Inc. | 67.67 Million USD | 170.508% |
IRIDEX Corporation | -4.28 Million USD | -1012.853% |
PROCEPT BioRobotics Corporation | -178.01 Million USD | 73.194% |
Tivic Health Systems, Inc. | -3.02 Million USD | -1476.971% |
INVO Bioscience, Inc. | 8.45 Million USD | 664.648% |
Telesis Bio, Inc. | 32.63 Million USD | 246.221% |
Viemed Healthcare, Inc. | -2.5 Million USD | -1807.14% |
Varex Imaging Corporation | 316.9 Million USD | 115.058% |
Quipt Home Medical Corp. | 81.73 Million USD | 158.383% |
Inspira Technologies Oxy B.H.N. Ltd. | -2.78 Million USD | -1615.282% |
Pulmonx Corporation | -42.36 Million USD | -12.651% |
Dynatronics Corporation | 6.2 Million USD | 869.163% |
Modular Medical, Inc. | -8.04 Million USD | -493.374% |
ReShape Lifesciences Inc. | -4.29 Million USD | -1010.523% |
Semler Scientific, Inc. | -57.13 Million USD | 16.473% |
InMode Ltd. | -135.39 Million USD | 64.755% |
Bruker Corporation | 891.3 Million USD | 105.354% |
Cytosorbents Corporation | 4.18 Million USD | 1241.057% |
DexCom, Inc. | 2.02 Billion USD | 102.353% |
Align Technology, Inc. | -840.47 Million USD | 94.322% |
Viveve Medical, Inc. | -13.81 Million USD | -245.466% |
ZimVie Inc. | 450.41 Million USD | 110.594% |
Movano Inc. | -5.86 Million USD | -713.487% |
Cytek Biosciences, Inc. | -134.45 Million USD | 64.509% |
Nexalin Technology, Inc. | -575.76 Thousand USD | -8187.928% |
DIH Holdings US, Inc. Class A Common Stock | 1.98 Million USD | 2505.024% |
Tandem Diabetes Care, Inc. | 356.79 Million USD | 113.374% |
Profound Medical Corp. | -18.17 Million USD | -162.503% |
Insulet Corporation | 798.1 Million USD | 105.979% |
enVVeno Medical Corporation | -2.21 Million USD | -2051.45% |
Surmodics, Inc. | -12.01 Million USD | -297.196% |
iCAD, Inc. | -21.2 Million USD | -124.995% |
Nuwellis, Inc. | -2.81 Million USD | -1592.769% |
Biotricity, Inc. | 23.09 Million USD | 306.641% |
iRhythm Technologies, Inc. | 93.65 Million USD | 150.954% |
Aethlon Medical, Inc. | -4.5 Million USD | -960.034% |
InspireMD, Inc. | -8.04 Million USD | -493.153% |
PAVmed Inc. | 29.08 Million USD | 264.062% |
BIOLASE, Inc. | 11.34 Million USD | 520.655% |
Beyond Air, Inc. | 6.22 Million USD | 866.081% |
FONAR Corporation | -14.66 Million USD | -225.388% |
AxoGen, Inc. | 32.26 Million USD | 247.893% |
Vivani Medical, Inc. | 42 Thousand USD | 113717.036% |
Tactile Systems Technology, Inc. | -10.65 Million USD | -347.731% |
Inari Medical, Inc. | -7.16 Million USD | -566.375% |
UFP Technologies, Inc. | 40.77 Million USD | 217.033% |
QT Imaging Holdings, Inc. | 3.06 Million USD | 1655.067% |
Heart Test Laboratories, Inc. | -4.77 Million USD | -900.127% |
Tenon Medical, Inc. | -1.25 Million USD | -3702.323% |
Autonomix Medical, Inc. Common Stock | -7.6 Million USD | -527.388% |
Co-Diagnostics, Inc. | -11.92 Million USD | -300.117% |
AdaptHealth Corp. | 2.21 Billion USD | 102.152% |
Sintx Technologies, Inc. | 905 Thousand USD | 5372.835% |
NanoVibronix, Inc. | -3.27 Million USD | -1355.74% |
Quanterix Corporation | -132.95 Million USD | 64.11% |
Inspira Technologies Oxy B.H.N. Ltd. | -2.78 Million USD | -1615.282% |
Sensus Healthcare, Inc. | -22.36 Million USD | -113.365% |
Pacific Biosciences of California, Inc. | 753.71 Million USD | 106.331% |
TransMedics Group, Inc. | 121.13 Million USD | 139.394% |
ReWalk Robotics Ltd. | -26.18 Million USD | -82.273% |
NeuroMetrix, Inc. | -1.49 Million USD | -3100.33% |
Hyperfine, Inc. | -75.61 Million USD | 36.895% |
Establishment Labs Holdings Inc. | 152.18 Million USD | 131.355% |
Biomerica, Inc. | -3.38 Million USD | -1309.724% |
Bone Biologics Corporation | -3.02 Million USD | -1476.675% |
AVITA Medical, Inc. | -26.23 Million USD | -81.915% |
Bluejay Diagnostics, Inc. | -1.83 Million USD | -2495.674% |
Silk Road Medical, Inc | 64.42 Million USD | 174.072% |